HF
SPRY icon

HRT Financial’s ARS Pharmaceuticals SPRY Stock Holding History

HRT Financial’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-68,645
Closed -$799K – 4669
2025
Q4 		$799K Buy
+68,645
New +$668K ﹤0.01% 1857
2025
Q2 		– Sell
-23,845
Closed -$299K – 3467
2025
Q1 		$299K Buy
+23,845
New +$287K ﹤0.01% 1780
2023
Q2 		– Sell
-135,684
Closed -$883K – 3230
2023
Q1 		$883K Buy
+135,684
New +$1.04M 0.01% 1011
2022
Q1 		– Sell
-63,588
Closed -$423K – 3814
2021
Q4 		$423K Buy
63,588
+37,554
+144% +$305K ﹤0.01% 2021
2021
Q3 		$259K Buy
+26,034
New +$642K ﹤0.01% 2512

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return